{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T09:30:54Z","timestamp":1765877454410,"version":"3.48.0"},"reference-count":21,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"unspecified","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People\u2019s Republic of China","doi-asserted-by":"crossref","award":["2015BAI13B09"],"award-info":[{"award-number":["2015BAI13B09"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"crossref"}]},{"name":"BeiGene Ltd."},{"DOI":"10.13039\/501100005024","name":"Beijing Postdoctoral Research Foundation","doi-asserted-by":"publisher","award":["2023-ZZ-038"],"award-info":[{"award-number":["2023-ZZ-038"]}],"id":[{"id":"10.13039\/501100005024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2023,7,26]]},"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Recent preclinical studies have discovered unique synergism between radiotherapy and immune checkpoint inhibitors, which has already brought significant survival benefit in lung cancer. In locally advanced rectal cancer (LARC), neoadjuvant radiotherapy plus immune checkpoint inhibitors have also achieved surprisingly high pathological complete response (pCR) rates even in proficient mismatch-repair patients. As existing researches are all phase 2, single-cohort trials, we aim to conduct a randomised, controlled trial to further clarify the efficacy and safety of this novel combination therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>Eligible patients with LARC are randomised to three arms (two experiment arms, one control arm). Patients in all arms receive long-course radiotherapy plus concurrent capecitabine as neoadjuvant therapy, as well as radical surgery. Distinguishingly, patients in arm 1 also receive anti-PD-1 (Programmed Death 1) treatment starting at Day 8 of radiation (concurrent plan), and patients in arm 2 receive anti-PD-1 treatment starting 2 weeks after completion of radiation (sequential plan). Tislelizumab (anti-PD-1) is scheduled to be administered at 200\u2009mg each time for three consecutive times, with 3-week intervals. Randomisation is stratified by different participating centres, with a block size of 6. The primary endpoint is pCR rate, and secondary endpoints include neoadjuvant-treatment-related adverse event rate, as well as disease-free and overall survival rates at 2, 3 and 5 years postoperation. Data will be analysed with an intention-to-treat approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This protocol has been approved by the institutional ethical committee of Beijing Friendship Hospital (the primary centre) with an identifying serial number of 2022-P2-050-01. Before publication to peer-reviewed journals, data of this research will be stored in a specially developed clinical trial database.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05245474\">NCT05245474<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2022-069499","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T20:40:42Z","timestamp":1694551242000},"page":"e069499","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Long-course chemoradiation plus concurrent\/sequential PD-1 blockade as neoadjuvant treatment for MMR-status-unscreened locally advanced rectal cancer: protocol of a multicentre, phase 2, randomised controlled trial (the POLAR-STAR trial)"],"prefix":"10.1136","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct05245474","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04231552","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5991-1728","authenticated-orcid":false,"given":"Kai","family":"Pang","sequence":"first","affiliation":[{"name":"General Surgery, Capital Medical University Affiliated Beijing Friendship Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Yang","sequence":"additional","affiliation":[{"name":"General Surgery, Capital Medical University Affiliated Beijing Friendship Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Tian","sequence":"additional","affiliation":[{"name":"General Surgery, Capital Medical University Affiliated Beijing Friendship Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Zeng","sequence":"additional","affiliation":[{"name":"National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Cao","sequence":"additional","affiliation":[{"name":"General Surgery, Capital Medical University Affiliated Beijing Friendship Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shen","family":"Ling","sequence":"additional","affiliation":[{"name":"General Surgery, Capital Medical University Affiliated Beijing Friendship Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5741-0076","authenticated-orcid":false,"given":"Jiale","family":"Gao","sequence":"additional","affiliation":[{"name":"General Surgery, Capital Medical University Affiliated Beijing Friendship Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"Zhao","sequence":"additional","affiliation":[{"name":"Radiotherapy and Radiation Oncology, Capital Medical University Affiliated Beijing Friendship Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[{"name":"Statistics and Methodology, Capital Medical University Affiliated Beijing Friendship Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2586-1443","authenticated-orcid":false,"given":"Yuanyuan","family":"Kong","sequence":"additional","affiliation":[{"name":"Statistics and Methodology, Capital Medical University Affiliated Beijing Friendship Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Radiology, Capital Medical University Affiliated Beijing Friendship Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangyong","family":"Chen","sequence":"additional","affiliation":[{"name":"Clinical Pathology, Capital Medical University Affiliated Beijing Friendship Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Deng","sequence":"additional","affiliation":[{"name":"General Surgery, Capital Medical University Affiliated Beijing Friendship Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigang","family":"Bai","sequence":"additional","affiliation":[{"name":"General Surgery, Capital Medical University Affiliated Beijing Friendship Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Jin","sequence":"additional","affiliation":[{"name":"General Surgery, Capital Medical University Affiliated Beijing Friendship Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoju","family":"Wu","sequence":"additional","affiliation":[{"name":"Gastrointestinal Surgery, Beijing Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danyang","family":"Zhu","sequence":"additional","affiliation":[{"name":"General Surgery, Peking Union Medical College Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[{"name":"General Surgery, Peking Union Medical College Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaolin","family":"Zhou","sequence":"additional","affiliation":[{"name":"General Surgery, Peking Union Medical College Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Wu","sequence":"additional","affiliation":[{"name":"General Surgery, Peking Union Medical College Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guole","family":"Lin","sequence":"additional","affiliation":[{"name":"General Surgery, Peking Union Medical College Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Xiao","sequence":"additional","affiliation":[{"name":"General Surgery, Peking Union Medical College Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8415-7587","authenticated-orcid":false,"given":"Zhidong","family":"Gao","sequence":"additional","affiliation":[{"name":"Gastrointestinal Surgery, Peking University People's Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingjiang","family":"Ye","sequence":"additional","affiliation":[{"name":"Gastrointestinal Surgery, Peking University People's Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[{"name":"General Surgery, Peking University First Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ang","family":"Li","sequence":"additional","affiliation":[{"name":"General Surgery, Xuanwu Hospital Capital Medical University, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiagang","family":"Han","sequence":"additional","affiliation":[{"name":"General Surgery, Beijing Chao-Yang Hospital Capital Medical University, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwei","family":"Yao","sequence":"additional","affiliation":[{"name":"General Surgery, Capital Medical University Affiliated Beijing Friendship Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingchi","family":"Yang","sequence":"additional","affiliation":[{"name":"General Surgery, Capital Medical University Affiliated Beijing Friendship Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4718-6821","authenticated-orcid":false,"given":"Zhongtao","family":"Zhang","sequence":"additional","affiliation":[{"name":"General Surgery, Capital Medical University Affiliated Beijing Friendship Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,9,12]]},"reference":[{"key":"2025121601264553000_13.9.e069499.1","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/cncr.33445","article-title":"Clinical characteristics, medical service utilization, and expenditure for colorectal cancer in China, 2005 to 2014: overall design and results from a multicenter retrospective epidemiologic survey","volume":"127","author":"Shi","year":"2021","journal-title":"Cancer"},{"key":"2025121601264553000_13.9.e069499.2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2016.0108"},{"key":"2025121601264553000_13.9.e069499.3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.7629"},{"key":"2025121601264553000_13.9.e069499.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040694"},{"key":"2025121601264553000_13.9.e069499.5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.40.1836"},{"key":"2025121601264553000_13.9.e069499.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1514296"},{"key":"2025121601264553000_13.9.e069499.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.01.002"},{"key":"2025121601264553000_13.9.e069499.8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.semcancer.2021.03.036","article-title":"Predictive biomarkers for response to immune checkpoint inhibition","volume":"79","author":"Shum","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"2025121601264553000_13.9.e069499.9","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-0180"},{"key":"2025121601264553000_13.9.e069499.10","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302014"},{"key":"2025121601264553000_13.9.e069499.11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/annonc\/mdx790","article-title":"Radiotherapy and anti-PD-1\/PD-L1 combinations in lung cancer: building better translational research platforms","volume":"29","author":"Kordbacheh","year":"2018","journal-title":"Ann Oncol"},{"key":"2025121601264553000_13.9.e069499.12","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003554","article-title":"Phase II, single-arm trial of preoperative short-course radiotherapy followed by chemotherapy and camrelizumab in locally advanced Rectal cancer","volume":"9","author":"Lin","year":"2021","journal-title":"J Immunother Cancer"},{"key":"2025121601264553000_13.9.e069499.13","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-020-01673-6","article-title":"Efficacy and safety-in analysis of short-course radiation followed by mFOLFOX-6 plus avelumab for locally advanced rectal adenocarcinoma","volume":"15","author":"Shamseddine","year":"2020","journal-title":"Radiat Oncol"},{"key":"2025121601264553000_13.9.e069499.14","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2021.05.016","article-title":"Phase II study of preoperative chemoradiotherapy plus avelumab in patients with locally advanced rectal cancer: the AVANA study","volume":"32","author":"Salvatore","year":"2021","journal-title":"Ann Oncol"},{"key":"2025121601264553000_13.9.e069499.15","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1158\/1078-0432.CCR-21-3213","article-title":"Preoperative chemoradiotherapy plus nivolumab before surgery in patients with microsatellite stable and microsatellite instability-high locally advanced rectal cancer","volume":"28","author":"Bando","year":"2022","journal-title":"Clin Cancer Res"},{"key":"2025121601264553000_13.9.e069499.16","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1057947","article-title":"Interim result of phase II, prospective, single-arm trial of long-course chemoradiotherapy combined with concurrent tislelizumab in locally advanced rectal cancer","volume":"13","author":"Gao","year":"2023","journal-title":"Front Oncol"},{"key":"2025121601264553000_13.9.e069499.17","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s40265-020-01286-z","article-title":"Tislelizumab: first approval","volume":"80","author":"Lee","year":"2020","journal-title":"Drugs"},{"key":"2025121601264553000_13.9.e069499.18","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.1016\/S1470-2045(21)00053-X","article-title":"The concept and use of the neoadjuvant rectal score as a composite endpoint in rectal cancer","volume":"22","author":"Glynne-Jones","year":"2021","journal-title":"Lancet Oncol"},{"key":"2025121601264553000_13.9.e069499.19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jclinepi.2015.08.007","article-title":"Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust","volume":"69","author":"Giesinger","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"2025121601264553000_13.9.e069499.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"2025121601264553000_13.9.e069499.21","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70172-8"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2022-069499","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T09:27:04Z","timestamp":1765877224000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2022-069499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":21,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9,12]]},"published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1136\/bmjopen-2022-069499"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2022-069499","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}